Lanthanum carbonate: Difference between revisions
Appearance
Content deleted Content added
Script assisted update of identifiers from ChemSpider, CommonChemistry and FDA for the Chem/Drugbox validation project - Updated: InChI1->InChI StdInChI StdInChIKey. |
No edit summary |
||
(66 intermediate revisions by 47 users not shown) | |||
Line 1: | Line 1: | ||
{{short description|Ore of lanthanum metal}} |
|||
{{Chembox |
{{Chembox |
||
| Verifiedfields = changed |
|||
| Name = Lanthanum carbonate |
|||
| Watchedfields = changed |
|||
| ImageFile = |
|||
| verifiedrevid = 400130079 |
|||
<!-- | ImageSize = 200px --> |
|||
| Name = Lanthanum carbonate |
|||
| ImageName = |
|||
| |
| = Lanthanumcarbonate |
||
| |
| = |
||
| IUPACName = Lanthanum carbonate |
|||
| Section1 = {{Chembox Identifiers |
|||
| OtherNames = Fosrenol |
|||
| ChemSpiderID = 147758 |
|||
|Section1={{Chembox Identifiers |
|||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|||
| ChemSpiderID = 147758 |
|||
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
|||
| ChEMBL = 2096647 |
|||
| PubChem = 168924 |
| PubChem = 168924 |
||
| KEGG = D04667 |
|||
| InChI = 1/3CH2O3.2La/c3*2-1(3)4;;/h3*(H2,2,3,4);;/q;;;2*+3/p-6 |
| InChI = 1/3CH2O3.2La/c3*2-1(3)4;;/h3*(H2,2,3,4);;/q;;;2*+3/p-6 |
||
| InChIKey = NZPIUJUFIFZSPW-CYFPFDDLAT |
| InChIKey = NZPIUJUFIFZSPW-CYFPFDDLAT |
||
| SMILES = [La+3].[La+3].O=C([O-])[O-].[O-]C([O-])=O.[O-]C([O-])=O |
| SMILES = [La+3].[La+3].O=C([O-])[O-].[O-]C([O-])=O.[O-]C([O-])=O |
||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|||
| StdInChI = 1S/3CH2O3.2La/c3*2-1(3)4;;/h3*(H2,2,3,4);;/q;;;2*+3/p-6 |
| StdInChI = 1S/3CH2O3.2La/c3*2-1(3)4;;/h3*(H2,2,3,4);;/q;;;2*+3/p-6 |
||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|||
| StdInChIKey = NZPIUJUFIFZSPW-UHFFFAOYSA-H |
| StdInChIKey = NZPIUJUFIFZSPW-UHFFFAOYSA-H |
||
| CASNo_Ref = {{cascite|correct|CAS}} |
|||
| CASNo = 54451-24-0 |
|||
| |
| = |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
}} |
|||
| UNII = 0M78EU4V9H |
|||
| Section2 = {{Chembox Properties |
|||
| EC_number = 209-599-5 |
|||
| Formula = La<sub>2</sub>(CO<sub>3</sub>)<sub>3</sub> |
|||
}} |
|||
| MolarMass = 457.85 g/mol |
|||
|Section2={{Chembox Properties |
|||
| Appearance = White, hygroscopic |
|||
| Formula = La{{sub|2}}(CO<sub>3</sub>)<sub>3</sub> |
|||
| Density = 2.6–2.7 g/cm{{sup|3}} |
|||
| MolarMass = 457.838 g/mol |
|||
| Solubility = Insoluble |
|||
| Appearance = White powder, hygroscopic |
|||
| MeltingPt = ''decomposes'' |
|||
| Density = 2.6–2.7 g/cm{{sup|3}} |
|||
| BoilingPt = |
|||
| Solubility = negligible |
|||
| pKa = |
|||
| SolubleOther = soluble in acids |
|||
| pKb = |
|||
| MeltingPt = ''decomposes'' |
|||
| BoilingPt = |
|||
| pKa = |
|||
| pKb = |
|||
}} |
}} |
||
| |
|Section3={{Chembox Structure |
||
| |
| Coordination = |
||
| |
| CrystalStruct = |
||
| |
| Dipole = |
||
}} |
}} |
||
| |
| = {{Chembox |
||
| Pharmacology_ref = |
|||
| ExternalMSDS = |
|||
| |
| = |
||
| |
| = |
||
| |
| = |
||
| |
| = |
||
| Licence_EU = |
|||
| INN = |
|||
| INN_EMA = |
|||
| Licence_US = |
|||
| Legal_status = |
|||
| Legal_AU = |
|||
| Legal_AU_comment = |
|||
| Legal_CA = Rx-only |
|||
| Legal_CA_comment = |
|||
| Legal_NZ = |
|||
| Legal_NZ_comment = |
|||
| Legal_UK = |
|||
| Legal_UK_comment = |
|||
| Legal_US = |
|||
| Legal_US_comment = |
|||
| Legal_EU = |
|||
| Legal_EU_comment = |
|||
| Legal_UN = |
|||
| Legal_UN_comment = |
|||
| Pregnancy_category = |
|||
| Pregnancy_AU = |
|||
| Pregnancy_AU_comment = |
|||
| Dependence_liability = |
|||
| AdminRoutes = |
|||
| Bioavail = |
|||
| ProteinBound = |
|||
| Metabolism = |
|||
| Metabolites = |
|||
| OnsetOfAction = |
|||
| HalfLife = |
|||
| DurationOfAction = |
|||
| Excretion = |
|||
}} |
}} |
||
| |
|={{Chembox |
||
| ExternalSDS = |
|||
| OtherAnions = [[Lanthanum(III) oxide]] |
|||
| |
| = |
||
| FlashPt = |
|||
}} |
}} |
||
|Section8={{Chembox Related |
|||
| OtherAnions = [[Lanthanum(III) oxide]] |
|||
| OtherCompounds = |
|||
}} |
}} |
||
}} |
|||
'''Lanthanum carbonate''', [[Lanthanum|La]]<sub>2</sub>([[Carbon|C]][[Oxygen|O]]<sub>3</sub>)<sub>3</sub>, is the [[salt]] formed by [[lanthanum]](III) [[cation]]s and [[carbonate]] [[anion]]s. It is an ore of [[lanthanum]] metal, along with [[monazite]]. |
|||
'''Lanthanum carbonate''', [[Lanthanum|La]]{{sub|2}}([[Carbon|C]][[Oxygen|O]]<sub>3</sub>)<sub>3</sub>, is the [[salt (chemistry)|salt]] formed by [[lanthanum]](III) [[cation]]s and [[carbonate]] [[anion]]s. It is an ore of [[lanthanum]] metal ([[bastnäsite]]), along with [[monazite]]. |
|||
== Chemistry == |
== Chemistry == |
||
Line 52: | Line 102: | ||
* for production of certain [[High-temperature superconductivity|high-temperature superconductors]], such as La{{sub|2-''x''}}Sr{{sub|''x''}}CuO{{sub|2}}. |
* for production of certain [[High-temperature superconductivity|high-temperature superconductors]], such as La{{sub|2-''x''}}Sr{{sub|''x''}}CuO{{sub|2}}. |
||
== Medical uses == |
|||
== Human and veterinary medicine == |
|||
Lanthanum carbonate is used in [[medicine]] as a [[phosphate binder]]<ref>{{cite web |
Lanthanum carbonate is used in [[medicine]] as a [[phosphate binder]]<ref>{{cite web|last=Editorial Staff |title=Lanthanum Carbonate |work=All Micromedex Systems |publisher=Micromedex, Inc. |=December 2004 |url=http://www.micromedex.com/products/updates/drugdex_updates/de/lanthanum.html |accessdate=2007-11-25 |archiveurl=://web.archive.org/web/20070914035811/http://www.micromedex.com/products/updates/drugdex_updates/de/lanthanum.html |archivedate=2007-09-14}}</ref> As a medication it is sold under the trade name '''Fosrenol''' by the pharmaceutical company [[Shire Pharmaceuticals]]. in chewed. It is [[medical prescription|prescribed]] for the treatment of [[hyperphosphatemia]], primarily in patients with [[chronic kidney disease]]. It is taken with meals and binds to dietary [[phosphate]], preventing phosphate from being absorbed by the [[intestine]]. For cats [[hyperphosphatemia]] it is available under the trade name '''Renalzin''' by [[Bayer|Bayer Animal Health]].<ref>{{cite web | author = Bayer Animal Health | url = http://www.animalhealth.bayerhealthcare.com/fileadmin/presslounge/att/2008-09-0441E.pdf | date = 26 September 2008 | title = Bayer Animal Health launches Renalzin for Cats | accessdate = 2008-09-30}}</ref> |
||
However, when lanthanum carbonate is used for treating hyperphosphatemia, its side effects, namely [[myalgia]], muscular cramping, and [[peripheral edema]], should be clinically monitored.<ref>{{cite journal |doi=10.1056/NEJMra0912522|pmid=20375408|title=Oral Phosphate Binders in Patients with Kidney Failure|journal=New England Journal of Medicine|volume=362|issue=14|pages=1312–24|year=2010|last1=Tonelli|first1=Marcello|last2=Pannu|first2=Neesh|last3=Manns|first3=Braden|s2cid=22322676}}</ref> |
|||
== Other applications == |
== Other applications == |
||
Lanthanum carbonate is also used for the tinting of glass, for water treatment, |
Lanthanum carbonate is also used for the tinting of glass, for water treatment, as a [[Catalysis|catalyst]] for [[cracking (chemistry)|hydrocarbon cracking]]. |
||
== References == |
== References == |
||
Line 62: | Line 114: | ||
== External links == |
== External links == |
||
* [ |
* [://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a605015.html Lanthanum] - medlineplus.org |
||
* [ |
* [://.fosrenol.com/Consumers/Default.aspx Fosrenol.com] - the manufacturer's web site |
||
* [ |
* [://www.drugs.com/NDA/fosrenol_040720.html Fosrenol] - Drugs.com |
||
* [http://www.medscape.com/pages/sites/infosite/fosrenol/fosrenol-intro?src=hp17.isite Fosrenol] - Medscape.com |
* [http://www.medscape.com/pages/sites/infosite/fosrenol/fosrenol-intro?src=hp17.isite Fosrenol] - Medscape.com |
||
* [ |
* [://.phosphoruscontrol.com PhosphorusControl.com] - PhosphorusControl.com |
||
* [http://www.animalhealth.bayerhealthcare.com Bayer Animal Health] |
* [http://www.animalhealth.bayerhealthcare.com Bayer Animal Health] |
||
{{Lanthanum compounds}} |
{{Lanthanum compounds}} |
||
{{Carbonates}} |
|||
{{Drugs for treatment of hyperkalemia and hyperphosphatemia}} |
{{Drugs for treatment of hyperkalemia and hyperphosphatemia}} |
||
[[Category:Nephrology procedures]] |
|||
[[Category:Phosphate binders]] |
[[Category:Phosphate binders]] |
||
[[Category:Lanthanum compounds]] |
[[Category:Lanthanum compounds]] |
||
[[Category:Carbonates]] |
[[Category:Carbonates]] |
||
[[Category:Metal-containing drugs]] |
|||
[[Category:Drugs developed by Takeda Pharmaceutical Company]] |
|||
[[de:Lanthancarbonat]] |
|||
[[es:Carbonato de lantano]] |
|||
[[nl:Lanthaniumcarbonaat]] |
|||
[[sr:Лантан-карбонат]] |